ISSN: 1083-8791

Journal Home

Journal Guideline

Biology of Blood and Marrow Transplantation Q1 Unclaimed

Elsevier Inc. United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Biology of Blood and Marrow Transplantation is a journal indexed in SJR in Hematology and Transplantation with an H index of 126. It has a price of 1260 €. It has an SJR impact factor of 1,397 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,397.

Biology of Blood and Marrow Transplantation focuses its scope in these topics and keywords: transplantation, cell, patients, hematopoietic, stem, allogeneic, graftversushost, cd, treatment, multiple, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Categories: Hematology (Q1) Transplantation (Q1)

Price

1260 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

Biology of Blood and Marrow Transplantation

1,397

SJR Impact factor

126

H Index

1

Total Docs (Last Year)

1179

Total Docs (3 years)

8

Total Refs

4918

Total Cites (3 years)

1069

Citable Docs (3 years)

4.24

Cites/Doc (2 years)

8.0

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Journal of Hematology and Oncology Q1
Blood Q1
Blood Cancer Journal Q1
The Lancet Haematology Q1
Leukemia Q1

Compare this journals

Aims and Scope

Best articles by citations

Effective purging of autologous hematopoietic stem cells using anti-B-cell monoclonal antibody-coated high-density microparticles prior to high-dose therapy for patients with non-Hodgkin's lymphoma

Administration of daniplestim and granulocyte colony-stimulating factor for the mobilization of hematopoietic progenitor cells in nonhuman primates

Community-acquired respiratory syncytial virus and parainfluenza virus infections after hematopoietic stem cell transplantation: The Fred Hutchinson Cancer Research Center experience

Psoralen and ultraviolet A irradiation (PUVA) as therapy for steroid-resistant cutaneous acute graft-versus-host disease

"Pet Negativity" - The New Goal of Cytoreductive Therapy in Hodgkin's Lymphoma?

Autologous stem cell transplantation for small cell lung cancer

Ex vivo expansion of immature 4-hydroperoxycyclophosphamide-resistant progenitor cells from G-CSF-mobilized peripheral blood

An Assay for Human Hematopoietic Stem Cells Based on Transplantation into Nonobese Diabetic Recombination Activating Gene-Null Perforin-Null Mice

Autologous versus allogeneic unrelated donor transplantation for acute lymphoblastic leukemia: Comparative toxicity and outcomes

Interleukin-2-activated autologous bone marrow and peripheral blood stem cells in the treatment of acute leukemia and lymphoma

Outcomes of Advanced Hodgkin Lymphoma after Umbilical Cord Blood Transplantation: A Eurocord and EBMT Lymphoma and Cellular Therapy & Immunobiology Working Party Study

"Nonmyeloablative regimen preserves ""niches"" allowing for peripheral expansion of donor T-cells"

SHOW MORE ARTICLES

Renal pathology at autopsy in patients who died after hematopoietic stem cell transplantation

Evaluation and Automation of Hematopoietic Chimerism Analysis Based on Real-Time Quantitative Polymerase Chain Reaction

The impact of induction duration and the number of high-dose cycles on the long-term survival of women with metastatic breast cancer treated with high-dose chemotherapy with stem cell rescue: An analysis of sequential phase I/II trials from the Dana-

Intravenous immunoglobulin: Appropriate indications and uses in hematopoietic stem cell transplantation

Gemcitabine, Fludarabine, and Melphalan for Reduced-Intensity Conditioning and Allogeneic Stem Cell Transplantation for Relapsed and Refractory Hodgkin Lymphoma

Antileukemic effect of interleukin-2-transduced murine bone marrow after autologous transplantation

Effect of c-mpl ligands after total body irradiation (TBI) with and without allogeneic hematopoietic stem cell transplantation: Low-dose TBI does not prevent sensitization

Efficacy and safety of monoclonal anti-CD20 antibody (rituximab) for the treatment of patients with recurrent low-grade non-Hodgkin's lymphoma after high-dose chemotherapy and autologous hematopoietic cell transplantation

Prophylactic antithymocyte globulin reduces the risk of chronic graft-versus-host disease in alternative-donor bone marrow transplants

Evaluation of safety and pharmacokinetics of administering intravenous busulfan in a twice-daily or daily schedule to patients with advanced hematologic malignant disease undergoing stem cell transplantation

Correction of phenotype in a thalassemia mouse model using a nonmyeloablative marrow transplantation regimen